FDA Issues Warning for 2 Diabetes Drugs Linked to Increased Heart Failure Risk

Share it with your friends Like

Thanks! Share it with your friends!

Close

By Mike Barrett

Following the results of 2 clinical trials, the Food and Drug Administration has issued warnings for diabetes medications containing saxagliptin and alogliptin. These medications have been shown to increase the risk of heart failure, especially for those who already suffer from heart or kidney disease.

An FDA statement notes:

“Healthcare professionals should consider discontinuing medications containing saxagliptin and alogliptin in patients who develop heart failure and monitor their diabetes control. If a patient’s blood sugar level is not well-controlled with their current treatment, other diabetes medicines may be required.”

  • Rating:
  • Views:632 views
  • Categories: Health